Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut
Researchers at Michigan Medicine have successfully reversed a severe and often intractable form of fatty liver disease in animal studies by focusing on an unexpected entry point for hepatic damage:…
Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut
An experimental drug developed by researchers at Michigan Medicine has successfully reversed a severe and often intractable form of fatty liver disease in animal studies. Rather than focusing exclusively on…
Experimental Michigan Medicine Drug Reverses Severe Fatty Liver Disease by Targeting the Gut
Researchers at Michigan Medicine have successfully reversed a severe and complex form of fatty liver disease in animal studies by focusing on an unexpected therapeutic target: the gastrointestinal tract. The…
Yale Researchers Discover Epilepsy Drug Paired with Smart Hydrogel Can Reverse Cartilage Damage and Relieve Osteoarthritis Pain
For millions of people living with osteoarthritis, the daily reality is often defined by a persistent, grinding cycle of pain, joint stiffness, and a steadily declining ability to perform everyday…
Yale Researchers Discover Epilepsy Drug Paired with Smart Hydrogel Can Both Relieve Osteoarthritis Pain and Repair Cartilage
For millions of people worldwide living with osteoarthritis, the daily reality is defined by a slow, painful deterioration of joint health. Everyday activities—from climbing a flight of stairs to walking…
Yale Researchers Discover Epilepsy Drug Paired with Smart Hydrogel Can Re-engineer Osteoarthritis Treatment and Reverse Joint Damage
For millions of people living with osteoarthritis, the daily reality is defined by a slow, creeping decline in mobility accompanied by persistent pain and joint stiffness. Standard therapeutic options—ranging from…
Experimental Drug CS18 Shows Promise in Overcoming Therapy-Resistant Tumors, Baylor Researchers Find
Researchers at the Baylor College of Medicine have developed an experimental small-molecule drug known as CS18 that offers a potential new avenue for tackling tumors that have grown resistant to…